Canadá - inglés - Health Canada

genmed a division of pfizer canada ulc - diclofenac sodium; misoprostol - tablet (delayed-release) - 75mg; 200mcg - diclofenac sodium 75mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

sandoz canada incorporated - diclofenac sodium; misoprostol - tablet - 50mg; 200mcg - diclofenac sodium 50mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

sandoz canada incorporated - diclofenac sodium; misoprostol - tablet - 75mg; 200mcg - diclofenac sodium 75mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

pharmascience inc - diclofenac sodium; misoprostol - tablet (delayed-release) - 50mg; 200mcg - diclofenac sodium 50mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Canadá - inglés - Health Canada

pharmascience inc - diclofenac sodium; misoprostol - tablet (delayed-release) - 75mg; 200mcg - diclofenac sodium 75mg; misoprostol 200mcg - other nonsteroidal antiimflammatory agents

Estados Unidos - inglés - NLM (National Library of Medicine)

dash pharmaceuticals llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac sodium and misoprostol delayed-release tablets and other treatment options before deciding to use diclofenac sodium and misoprostol delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. diclofenac sodium and misoprostol delayed-release tablets should not be taken by pregnant women. diclofenac sodium and misoprostol delayed-releas

Estados Unidos - inglés - NLM (National Library of Medicine)

bryant ranch prepack - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol 200 ug

Estados Unidos - inglés - NLM (National Library of Medicine)

blenheim pharmacal, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 75 mg - carefully consider the potential benefits and risks of diclofenac sodium and misoprostol delayed-release tablets and other treatment options before deciding to use diclofenac sodium and misoprostol delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings , gastrointestinal effects - risk of ulceration, bleeding, and perforation   for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings   related to misoprostol. diclofenac sodium and misoprostol delayed-release tablets should not be taken by pregnant women. dic

Estados Unidos - inglés - NLM (National Library of Medicine)

apotheca, inc - misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - misoprostol 200 ug - see boxed warnings. misoprostol should not be taken by pregnant women to reduce the risk of ulcers induced by non-steroidal anti-inflammatory drugs (nsaids). misoprostol should not be taken by anyone with a history of allergy to prostaglandins.

Estados Unidos - inglés - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 75 mg - carefully consider the potential benefits and risks of arthrotec and other treatment options before deciding to use arthrotec. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). arthrotec is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding, and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. arthrotec should not be taken by pregnant women. arthrotec is contraindicated in patients with hypersensitivity to diclofenac or to misoprostol or other prostaglandins. arthrotec should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after